Prognostic significance of fibrosis markers in hepatocellular carcinoma among patients with IFN-based therapy
Nakagawa, M.; Asahina, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 668-673
2015
ISSN/ISBN: 0047-1852 PMID: 26846019 Document Number: 685436
Document emailed within 1 workday
Related Documents
Ebelt, J.; Neid, M.; Tannapfel, A.; Witzigmann, H.; Hauss, J.; Köckerling, F.; Wittekind, C. 2000: Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC) Zentralblatt für Chirurgie 125(7): 597-601Tangkijvanich, P.; Janchai, A.; Charuruks, N.; Kullavanijaya, P.; Theamboonlers, A.; Hirsch, P.; Poovorawan, Y. 2000: Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma Asian Pacific Journal of Allergy and Immunology 18(4): 237-243
Watanuki, A.; Ohwada, S.; Fukusato, T.; Makita, F.; Yamada, T.; Kikuchi, A.; Morishita, Y. 2002: Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. Anticancer Research 22(2b): 1113-1119
Tarao, K.; Ohkawa, S.; Tamai, S.; Shimizu, A. 1995: Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 740-745
Shirabe, K.; Sugimachi, K.; Harimoto, N.; Tsujita, E.; Sugimachi, K.; Rikimaru, T.; Yamashita, Y.; Tanaka, S.; Shimada, M. 2001: Prognostic factors in patients with hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 367-372
Junik, R.; Piechowski, A.; Sowiński, J.; Wender, M. 1995: The thyroid function markers and their prognostic significance patients with ischemic stroke Neurologia i Neurochirurgia Polska 29(3): 317-323
Khin, L.W.; Teo, C.J.; Guan, R. 1996: Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore Singapore Medical Journal 37(5): 492-496
Yamauchi, M.; Yoshigoe, F.; Mera, F.; Ogura, K.; Kameda, H.; Nakada, J.; Takasaka, S.; Machida, T.; Fukunaga, M. 1983: An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers Gan no Rinsho. Japan Journal of Cancer Clinics 29(4): a
Zhang, L.; Ren, Z.-g.; Gan, Y.-h.; Wang, Y.-h.; Zhang, B.-h.; Chen, Y.; Xie, X.-y.; Ge, N.-l.; Ye, S.-l. 2010: Therapeutic efficacy and prognostic factors of sorafenib treatment in patients with unresectable primary hepatocellular carcinoma Zhonghua Zhong Liu Za Zhi 32(8): 630-633
Graziano, S.L.; Tatum, A.H.; Newman, N.B.; Oler, A.; Kohman, L.J.; Veit, L.J.; Gamble, G.P.; Coleman, M.J.; Barmada, S.; O'Lear, S. 1994: The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage i and Ii non-small cell lung cancer Cancer Research 54(11): 2908-2913
Zanoni, A.; Verlatoa, G.; Minicozzi, A.; Tomezzoli, A.; Giacopuzzi, S.; Di Cosmo, M.; Franceschetti, I.; Saladino, E.; De Manzoni, G. 2009: Prognostic significance of the Mandard TRG classification after induction therapy in carcinoma of the oesophagus and cardia Chirurgia Italiana 61(4): 419-425
Peng, J.; Cai, S.; Leng, X.; Mu, D.; Lu, J.; Chen, H.; Rui, J. 2002: MRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma Zhonghua Yu Fang Yi Xue Za Zhi 36(7): 487-490
Chang, Y.-s.; Huang, J.-s.; Yen, C.-l.; Wang, C.-h.; Lai, C.-h.; Wu, T.-h.; Lan, Y.-j.; Chang, P.-h.; Yeh, K.-y. 2015: The Charlson Comorbidity Index is an Independent Prognostic Factor for Treatment-Naïve Hepatocellular Carcinoma Patients with Extrahepatic Metastases Hepato-Gastroenterology 62(140): 1011-1015
Kawakita, T.; Shiraki, K.; Yamanaka, Y.; Yamaguchi, Y.; Saitou, Y.; Enokimura, N.; Yamamoto, N.; Okano, H.; Sugimoto, K.; Murata, K.; Yamakado, K.; Takeda, K.; Nakano, T. 2003: A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma International Journal of Oncology 23(4): 1115-1120
Yeh, J-Lin.; Peng, Y-Chun.; Tung, C-Fang.; Yang, D-Yu.; Hu, W-Hsiung.; Chow, W-Keung.; Yeh, H-Zen.; Chen, G-Hum. 2003: Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma Hepato-Gastroenterology 50(53): 1603-1608
Kitagawa, Y.; Ueda, M.; Ando, N.; Shinozawa, Y.; Shimizu, N.; Abe, O. 1991: Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma Cancer Research 51(5): 1504-1508
Bao, Y.-x.; Yang, Y.; Zhao, H.-r.; Mao, R.; Xiao, L.; Zhang, Y.-f.; Aisiker, T.; Wen, H. 2013: Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma Zhonghua Zhong Liu Za Zhi 35(7): 505-508
Akahane, Y. 2001: Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 474-477
Van Dyke, A.H.; Van Nagell, J.R. 1975: The prognostic significance of ureteral obstruction in patients with recurrent carcinoma of the cervix uteri Surgery Gynecology and Obstetrics 141(3): 371-373
Denlinger, C. 2019: Therapy Options for Patients with Hepatocellular Carcinoma Oncology 33(9)